Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma
PHASE1CompletedINTERVENTIONAL
Enrollment
14
Participants
Timeline
Start Date
January 11, 2013
Primary Completion Date
December 20, 2016
Study Completion Date
April 26, 2017
Conditions
Locally Advanced or Metastatic Melanoma
Interventions
BIOLOGICAL
ICOVIR-5
Trial Locations (1)
08908
Institut Català d'Oncologia - L'Hospitalet, L'Hospitalet Del Llobregat
All Listed Sponsors
lead
Institut Català d'Oncologia
OTHER
NCT01864759 - Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma | Biotech Hunter | Biotech Hunter